Zahra M, PharmD, MBA, BCOP, FHOPA
banner
kczmj.bsky.social
Zahra M, PharmD, MBA, BCOP, FHOPA
@kczmj.bsky.social
#Heme and #Cellular Therapeutics Clinical Pharmacy Manager @ University of Kansas Cancer Center | Secretary @ HOPA Board of Directors | All views my own | #oncopharm | #pharmsky
Reposted by Zahra M, PharmD, MBA, BCOP, FHOPA
Important work from @astct.bsky.social Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells #CARTcells www.sciencedirect.com/science/arti...
Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells
The first six chimeric antigen receptor T cell (CAR-T) therapies approved in the United States have Risk Evaluation Mitigation Strategies (REMS) progr…
www.sciencedirect.com
February 26, 2025 at 1:21 PM
Reposted by Zahra M, PharmD, MBA, BCOP, FHOPA
Phenomenal presentation by medical student (!) Lauren Scott at Univ Kansas Medical Center demonstrating low yield of MRI, LP and EEG in patients presenting with ICANS. Positive findings were present primarily in patients who already had focal findings. #ASH24 #immunotherapy
December 8, 2024 at 1:12 AM
Reposted by Zahra M, PharmD, MBA, BCOP, FHOPA
Still time to see poster #2300 - outpatient CART experience in 200+ patients treated across multi site Sarah Cannon Transplant and Cellular Therapy Network #ASH24
December 8, 2024 at 2:25 AM
Reposted by Zahra M, PharmD, MBA, BCOP, FHOPA
High prescription drug costs in the US hinder patient access to medication, but there are strategies that clinical teams can use to help patients manage these costs.

https://ja.ma/4eQizjM
November 30, 2024 at 4:00 PM